The “Digital Health Market: Focus On Digital Therapeutics (2nd Edition), 2020-2030

>

The “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030

To order this 500+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html

 

Key Inclusions

  • An overview of the current market landscape of digital therapeutic solutions, including information on status of development, type of solution (combination offering of software application + device or AI or personal coach, and standalone software application), type of therapy (curative and preventive), purpose of solution (medication replacement and medication augmentation), target disease indication(s), therapeutic area(s), and target population. In addition, it presents details of the companies developing digital therapeutic solution, highlighting year of establishment, company size, type of business model used (B2B and B2C) and location of headquarters.
  • An in depth analysis of the contemporary market trends, presented using four schematic representations, including [A] a bubble analysis comparing the leading players engaged in the development of digital therapeutic solutions based on the parameters, such as product portfolio strength, number of target disease indication(s) and company size, [B] a grid representation illustrating the distribution of the digital therapeutic solutions based on status of development, type of solution and therapeutic area, [C] an insightful tree map representation of the digital therapeutic solutions, distributed on the basis of therapeutic area and company size, and [D] a world map representation highlighting the regional distribution of developer companies.
  • A detailed product competitiveness analysis of digital therapeutic solutions developed / under development for the most popular therapeutic areas taking into consideration the strength of product portfolio (based on the total number of digital therapeutic solutions being developed in that disease area) and key product specific parameters, such as status of development, type of solution, type of therapy, and purpose of solution.
  • Elaborate profiles of prominent small-sized and mid-sized players that are either engaged in the development or have developed digital therapeutic solutions. Each company profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details of their respective product portfolio, recent developments and an informed future outlook.
  • A detailed analysis of more than 220 completed, ongoing and planned clinical studies of various digital therapeutic solutions, based on the various relevant parameters, such as trial registration year, trial phase, number of patients enrolled, study design, trial recruitment status and trial focus, highlighting leading sponsors and leading digital therapeutic solutions (in terms of number of trials conducted), type of organization, popular therapeutic areas and regional distribution of trials. In addition, it features an insightful clinical end-points analysis (for trials initiated since 2018 for popular therapeutic areas).
  • An analysis of the investments made in the period between 2009 and 2020 (till June), including seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings, at various stages of development in companies that are engaged in this field.
  • An analysis of the partnerships that have been inked by stakeholders in this domain, in the period between 2008 and 2020 (till May), covering clinical trial agreements, pilot product offerings, product integration agreements, product launch agreements, product / technology licensing agreements, marketing and distribution agreements, mergers / acquisitions, and research and development agreements.
  • A detailed analysis of the various business models and go-to-market strategies adopted by companies involved in this space, providing details on various channels adopted / being adopted by stakeholders in the industry to raise awareness and offer access to their proprietary products.
  • A Bowman’s Strategy Clock framework in order to analyze the competitive position of various companies in the marketplace, taking into consideration the prices and different features of their products.
  • An insightful discussion on the impact of COVID-19 pandemic on the overall digital therapeutic solutions market, and the key initiatives undertaken by big pharma players.
  • A review of the key aspects related to the remote digital monitoring and diagnostics solutions, including [A] a brief introduction to remote digital monitoring and diagnostics solutions, highlighting the key benefits and roadblocks [B] an assessment of the market landscape of remote digital monitoring and diagnostics solutions, based on various parameters, such as status of development, type of solution, target disease indication(s) and therapeutic area, along with details on the companies that develop these solutions, highlighting year of establishment, company size and location of headquarters [C] detailed profiles of some of the key players that presently offer digital monitoring / diagnostic solutions for chronic disease management; each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters, lead investors, key partners and members of the executive team), details of their product portfolio, recent developments and an informed future outlook, and [D] an insightful analysis on various capital investments that have been made into the digital monitoring / diagnostics domain.
  • A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall digital therapeutic solutions industry.
  • An informative analysis of contemporary Google Trends in the time period between 2015 and 2020 (till July) and insights from the recent news articles related digital therapeutic solutions, indicating the increasing popularity of this domain. Furthermore, it highlights the potential future opportunities for players engaged in development of such solutions.

 

 

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 

  • Type of Solution
  • Standalone Software Application
  • Software Application + Device + Personal Coach
  • Software Application + Device + AI Support
  • Software Application + Device
  • Software Application + AI Support
  • Software Application + Personal Coach
  • Other Types of Solutions

 

  • Purpose of Solution
  • Medication Replacement
  • Medication Augmentation

 

  • Type of Therapy
  • Curative
  • Preventive

 

  • Business Model
  • Business to Consumer (Patients and Caregivers)
  • Business to Business (Healthcare Providers, Payers, Employers and Pharmaceutical Companies)

 

  • Therapeutic Areas
  • Cardiovascular Disorders
  • Chronic Pain
  • Mental Health Problems
  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Sleep Disorders
  • Substance Use Disorders
  • Others

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the world 

 

The report includes detailed transcripts of discussions held with the following experts:

  • Eran Ofir (Co-Founder and Chief Executive Officer, Somatix)
  • Edouard Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
  • Stephanie Tilenius (Co-Founder and Chief Executive Officer, Vida Health)
  • Adam Kaufman (Chief Executive Officer, Canary Health)
  • Vijay Ravindran (Chief Executive Officer, Floreo)
  • Palakh R Sarogi (Vice President, Marketing, Wellthy Therapeutics), Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics) and Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
  • Amelie Janson (Communication Manager, Voluntis)
  • Anonymous (Founder and Chief Executive Officer, UK based Small-sized Company)

 

To request sample pages, please visit this - https://www.rootsanalysis.com/reports/208/request-sample.html

 

Key Questions Answered

  • Who are the leading developers offering digital therapeutic solutions?
  • What are the most popular therapeutic areas for digital therapeutic solutions?
  • Which companies are actively involved in conducting clinical trials for their solutions?
  • What are the key factors influencing the price of digital therapeutic solutions?
  • What is the trend in capital investments in the digital therapeutics market?
  • Which partnership models are commonly adopted by stakeholders in this industry?
  • What type of marketing strategies are being adopted by developers in this domain?
  • What is the impact of COVID-19 outbreak on digital therapeutic solutions market?
  • What are the opportunities for digital therapeutic solutions in emerging markets?
  • How is the current and future opportunity likely to be distributed across key market segments?
  • What are the anticipated future trends related to digital therapeutic solutions market?

 

You may also be interested in the following titles:

  1. AR / VR Based Healthcare Digital Marketing Service Providers Market, 2020-2030
  2. AI-Based Clinical Trial Solution Providers Market, 2020-2030
  3. Global Handheld Ultrasound Imaging Devices Market, 2020-2030

 

Contact Us

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report

Comments

Other related blogs

Global Acrylic Teeth Market- Industry Analysis and Forecast (2020-2027)

By : Maximize Market

Global Acrylic Teeth Market is expected to reach US$ XX Mn by 2027, at a nearby CAGR of 10.2% during..


The nuclear medicine and radiopharmaceuticals manufacturing market is projected to grow at an annualized rate of over 10%, till 2030

By : Roots Analysis

  Roots Analysis has announced the addition of “Nuclear Medicine and Radiopharmaceutical..


The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030, predicts Roots Analysis

By : Roots Analysis

  The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applic..